Sonova H Ag (SOON) - Total Assets
Based on the latest financial reports, Sonova H Ag (SOON) holds total assets worth CHF5.63 Billion CHF (≈ $7.12 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Sonova H Ag to assess how comfortably operating cash covers total debt obligations.
Sonova H Ag - Total Assets Trend (2002–2026)
This chart illustrates how Sonova H Ag's total assets have evolved over time, based on quarterly financial data. See shareholders equity of Sonova H Ag for net asset value and shareholders' equity analysis.
Sonova H Ag - Asset Composition Analysis
Current Asset Composition (March 2026)
Sonova H Ag's total assets of CHF5.63 Billion consist of 37.0% current assets and 63.0% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 12.8% |
| Accounts Receivable | CHF665.10 Million | 11.8% |
| Inventory | CHF381.00 Million | 6.8% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF112.90 Million | 2.0% |
| Goodwill | CHF2.28 Billion | 40.6% |
Asset Composition Trend (2002–2026)
This chart illustrates how Sonova H Ag's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sonova H Ag (SOON) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sonova H Ag's current assets represent 37.0% of total assets in 2026, a decrease from 41.3% in 2002.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2026, up from 9.8% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 32.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 40.6% of total assets.
Sonova H Ag Competitors by Total Assets
Key competitors of Sonova H Ag based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.78 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
Sonova H Ag - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.75 | 1.27 | 2.09 |
| Quick Ratio | 1.43 | 0.96 | 1.85 |
| Cash Ratio | 0.00 | 0.46 | 1.41 |
| Working Capital | CHF895.10 Million | CHF411.20 Million | CHF1.37 Billion |
Sonova H Ag - Advanced Valuation Insights
This section examines the relationship between Sonova H Ag's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.75 |
| Latest Market Cap to Assets Ratio | 2.17 |
| Asset Growth Rate (YoY) | -5.0% |
| Total Assets | CHF5.63 Billion |
| Market Capitalization | $12.20 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Sonova H Ag's assets at a significant premium (2.17x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Sonova H Ag's assets decreased by 5.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sonova H Ag (2002–2026)
The table below shows the annual total assets of Sonova H Ag from 2002 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | CHF5.63 Billion ≈ $7.12 Billion |
-4.99% |
| 2025-03-31 | CHF5.92 Billion ≈ $7.49 Billion |
+2.29% |
| 2024-03-31 | CHF5.79 Billion ≈ $7.32 Billion |
+4.31% |
| 2023-03-31 | CHF5.55 Billion ≈ $7.02 Billion |
-0.64% |
| 2022-03-31 | CHF5.59 Billion ≈ $7.06 Billion |
-5.69% |
| 2021-03-31 | CHF5.93 Billion ≈ $7.49 Billion |
+32.08% |
| 2020-03-31 | CHF4.49 Billion ≈ $5.67 Billion |
+4.52% |
| 2019-03-31 | CHF4.29 Billion ≈ $5.43 Billion |
-0.22% |
| 2018-03-31 | CHF4.30 Billion ≈ $5.44 Billion |
+9.31% |
| 2017-03-31 | CHF3.94 Billion ≈ $4.98 Billion |
+43.03% |
| 2016-03-31 | CHF2.75 Billion ≈ $3.48 Billion |
+2.23% |
| 2015-03-31 | CHF2.69 Billion ≈ $3.40 Billion |
+3.77% |
| 2014-03-31 | CHF2.59 Billion ≈ $3.28 Billion |
-3.25% |
| 2013-03-31 | CHF2.68 Billion ≈ $3.39 Billion |
+17.21% |
| 2012-03-31 | CHF2.29 Billion ≈ $2.89 Billion |
+5.32% |
| 2011-03-31 | CHF2.17 Billion ≈ $2.75 Billion |
-9.86% |
| 2010-03-31 | CHF2.41 Billion ≈ $3.05 Billion |
+68.89% |
| 2009-03-31 | CHF1.43 Billion ≈ $1.80 Billion |
+12.06% |
| 2008-03-31 | CHF1.27 Billion ≈ $1.61 Billion |
+0.76% |
| 2007-03-31 | CHF1.26 Billion ≈ $1.60 Billion |
+36.12% |
| 2006-03-31 | CHF928.12 Million ≈ $1.17 Billion |
+24.86% |
| 2005-03-31 | CHF743.36 Million ≈ $939.81 Million |
+8.65% |
| 2004-03-31 | CHF684.21 Million ≈ $865.02 Million |
+12.74% |
| 2003-03-31 | CHF606.86 Million ≈ $767.24 Million |
-18.24% |
| 2002-03-31 | CHF742.25 Million ≈ $938.40 Million |
-- |
About Sonova H Ag
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service … Read more